Talking Point: Successes and challenges in reducing the harms of substance use - lessons learned from the Canadian experience

This talk will provide an overview of substance use trends in Canada over the last 10 years, including some of the unique challenges faced by Canada in regards to the collection of relevant data.

Details

When
Thursday 16 August 2018
1:00pm - 2:00pm

Where

Turning Point, Training Room 1, Level 1, 110 Church Street, Richmond VIC 3121

Getting to Turning Point: Trams on Church Street, Bridge Road and Victoria Street; nearest train stations are West and North Richmond; limited all day parking available in the area. Please allow sufficient time for parking, arrival at 12:45pm recommended.

If you have enquiries regarding registration please call (03) 8413 8700.

Cost
Free - there is no cost to attend but registrations are essential.

Register

Summary

This talk will provide an overview of substance use trends in Canada over the last 10 years, including some of the unique challenges faced by Canada in regards to the collection of relevant data. Specific areas of focus will include a discussion of the recent history of the current opioid crisis in Canada as well as findings from a recently released report on the economic burden of substance use in Canada.

The presentation will also include time for a discussion regarding the similarities and differences between substance use trends, policies, and interventions in Australia and Canada – with a focus on any lessons that may be learned from each other.

Presenter

Dr. Matthew M. Young, Ph.D., is a Senior Research and Policy Analyst at the Canadian Centre on Substance Use and Addiction (CCSA) and an Adjunct Research Professor of Psychology at Carleton University in Ottawa, Canada.

Matthew leads CCSA’s drug use epidemiology research activities, which includes work to estimate the economic burden of substance use in Canada, Canada’s early warning sentinel surveillance system, as well as CCSA’s work on Novel Psychoactive Substances (NPS). He also co-chairs the scientific committee tasked with developing Low Risk Gambling Guidelines.